Given the increasing frequency of Hematologic Malignancy, especially in an aging population, as well as the complexities of individual clinic presentation, there is a need to provide an opportunity for Oncologists, Hematologists and Oncology Nurses to engage in a thoughtful examination and discussion with experts in various hematologic cancers. There is also emerging data about the biology of these cancers that underlies modern optimal management of patients with these disorders. The expansion of patient care options in nearly all of these disorders makes decision making more complex. This two and a half-day symposium has been designed by experts in the field of hematologic malignancies and affords the conferee specialized educational tracks for both physicians and nurses providing the opportunity to learn about the most recent advances in the treatment of bone marrow transplant, multiple myeloma, lymphoma and leukemia. Updates on improved curative and palliative treatments and evolving molecular and immunologically-based system therapies, as well as important, completed or ongoing clinical trials, will be profiled and discussed.
Date:March 09, 2016
Time: 04:00 PM - 04:00 PM (PT)
Location:Mandarin Oriental, 3752 Las Vegas Blvd South, Las Vegas 89158
Agenda:Download agenda: https://cme.cityofhope.org/files/Brochure-%20FINAL.pdf
CME credits:ACCREDITATION STATEMENT: City of Hope is accredited by the California Board of Registered Nursing, Provider Number 158. education for physicians. CREDIT DESIGNATION: City of Hope designates this activity for a maximum of 17.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PLEASE NOTE: This activity is not accredited for AMA PRA Category 1 credit. The following credit type(s) are being offered for this course: